Effect of antiviral treatment and host susceptibility on positive selection in hepatitis C virus (HCV)

We have conducted a large sequence study of the E1–E2 and NS5A regions of the HCV, subtypes 1a and b, both in patients previously treated with interferon, and untreated patients, who later responded, or not, to a combination therapy based on interferon plus ribavirin. We have examined the role playe...

Full description

Saved in:
Bibliographic Details
Published inVirus research Vol. 131; no. 2; pp. 224 - 232
Main Authors Jiménez-Hernández, Nuria, Sentandreu, Vicente, Castro, José A., Torres-Puente, Manuela, Bracho, Alma, García-Robles, Inmaculada, Ortega, Enrique, del Olmo, Juan, Carnicer, Fernando, González-Candelas, Fernando, Moya, Andrés
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 01.02.2008
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:We have conducted a large sequence study of the E1–E2 and NS5A regions of the HCV, subtypes 1a and b, both in patients previously treated with interferon, and untreated patients, who later responded, or not, to a combination therapy based on interferon plus ribavirin. We have examined the role played by the number of positively selected sites on disease progression and its relationship with several variables such as patients’ age, sex and their risk of acquiring the disease. We have detected three groups of patients that respond or not to combination therapy: responders of intermediate age, older non-responders and young non-responders, they possess an increasing average number of positively selected sites in the E1–E2 region, respectively. We conclude that the host's genetic factors play an important role in whether the disease is contained or becomes chronic.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0168-1702
1872-7492
DOI:10.1016/j.virusres.2007.09.012